New radioactive drug targets Hard-to-Treat cancers

NCT ID NCT04939610

First seen Jun 25, 2026 · Last updated Jul 24, 2026 · Updated 2 times

Summary

This study tests a drug called 177Lu-FAP-2286, which delivers radiation directly to cancer cells. It is for people with advanced solid tumors (like pancreatic, lung, or breast cancer) that have a specific protein called FAP. The trial has two parts: Phase 1 finds the safest dose, and Phase 2 checks if the drug shrinks tumors, alone or with chemotherapy. About 222 adults will take part.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
177Lu-FAP-2286 (a radioactive drug that targets cancer cells)
What this could lead to
If it works, this could offer a new treatment option for people with advanced solid tumors like pancreatic, lung, or breast cancer.
What could go wrong
This is an early-phase trial, so the drug may not work or could cause serious side effects. It is only for patients whose tumors show a specific protein (FAP).

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • City of Hope

    RECRUITING

    Duarte, California, 91010, United States

  • Columbia University Medical Center

    RECRUITING

    New York, New York, 10032, United States

  • Fred Hutchinson Cancer Center

    RECRUITING

    Seattle, Washington, 98109-1023, United States

  • Hoag Hospital Irvine

    RECRUITING

    Irvine, California, 92618, United States

  • Karmanos Cancer Institute

    RECRUITING

    Detroit, Michigan, 48201, United States

  • London Health Sciences Centre

    RECRUITING

    Toronto, Ontario, M4N 3M5, Canada

  • Mayo Clinic

    RECRUITING

    Jacksonville, Florida, 32224, United States

  • Mayo Clinic

    RECRUITING

    Rochester, Minnesota, 55905, United States

  • Memorial Sloan Kettering Cancer Center

    RECRUITING

    New York, New York, 10065, United States

  • Novartis Investigating Site

    RECRUITING

    London, Ontario, N6A 5W9, Canada

  • Novartis Investigating Site

    RECRUITING

    Marseille, 13385, France

  • Novartis Investigating Site

    RECRUITING

    Milan, 20141, Italy

  • Novartis Investigating Site

    RECRUITING

    Reggio Emilia, 41123, Italy

  • Novartis Investigating Site

    RECRUITING

    Badalona, 08916, Spain

  • Novartis Investigating Site

    RECRUITING

    Madrid, 28040, Spain

  • Novartis Investigating Site

    RECRUITING

    Madrid, 28041, Spain

  • Novartis Investigating Site

    RECRUITING

    Madrid, 28050, Spain

  • Novartis Investigative Site

    RECRUITING

    Adelaide, South Australia, 5000, Australia

  • Novartis Investigative Site

    RECRUITING

    Melbourne, Victoria, 3000, Australia

  • Novartis Investigative Site

    RECRUITING

    Melbourne, Victoria, 3004, Australia

  • Novartis Investigative Site

    RECRUITING

    Montreal, Quebec, H4A 3J1, Canada

  • Novartis Investigative Site

    RECRUITING

    Meldola, Emilia-Romagna, 47014, Italy

  • Novartis Investigative Site

    RECRUITING

    A Coruña, 15006, Spain

  • Novartis Investigator Site

    RECRUITING

    Murdoch, Western Australia, 6150, Australia

  • Novartis Investigator Site

    RECRUITING

    Montpellier, Cedex 5, 34298, France

  • Novartis Investigator Site

    RECRUITING

    Bordeaux, 33000, France

  • Novartis Investigator Site

    RECRUITING

    Clermont-Ferrand, 63011, France

  • Novartis Investigator Site

    RECRUITING

    Vandœuvre-lès-Nancy, 54511, France

  • Novartis Investigator Site

    RECRUITING

    Naples, 80131, Italy

  • Oregon Health and Science University

    RECRUITING

    Portland, Oregon, 97239-3098, United States

  • Saint Louis University Hospital

    RECRUITING

    St Louis, Missouri, 63110-2539, United States

  • UAB Comprehensive Cancer Center

    RECRUITING

    Birmingham, Alabama, 35233, United States

  • UCSF Medical Center

    RECRUITING

    San Francisco, California, 94158, United States

  • UNC Hospitals

    RECRUITING

    Chapel Hill, North Carolina, 27514, United States

  • UPMC Hillman Cancer Center

    RECRUITING

    Pittsburgh, Pennsylvania, 15232, United States

  • Univ of Utah, Huntsman Cancer Institute

    RECRUITING

    Salt Lake City, Utah, 84112, United States

  • University of California Los Angeles (UCLA)

    RECRUITING

    Los Angeles, California, 90095, United States

  • University of Chicago Medical Center

    RECRUITING

    Chicago, Illinois, 60637, United States

  • University of Iowa Hospitals and Clinics

    RECRUITING

    Iowa City, Iowa, 52242, United States

  • University of Miami Hospital and Clinics

    RECRUITING

    Miami, Florida, 33136, United States

  • University of Texas MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.